Nov 11, 2020 / 01:30PM GMT
Operator
Good afternoon. This is the Chorus Call conference operator. Welcome, and thank you for joining the DiaSorin Third Quarter and 9 Months 2020 Results Conference Call. (Operator Instructions)
At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of DiaSorin. Please go ahead, sir.
Carlo Rosa - DiaSorin S.p.A. - CEO, GM & Executive Director
Yes. Thank you, operator, and good morning, good afternoon to everybody. Welcome to the quarter 3 conference call of DiaSorin. I will -- I think this time, we are going to make some short comments, and then I'm going to leave Mr. Pedron to go through the numbers, and then we're going to leave ample time to -- for Q&A because I see there are lots of questions, none, I believe, necessarily related to the results, but to the environment, the ecosystem after the [Pfizer] announcement a couple of days ago.
So I would start and comment on revenues. As you have seen, the quarter has been a very strong quarter, I think, in line with what we have seen also from other players in diagnostic
Q3 2020 DiaSorin SpA Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
